These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
545 related articles for article (PubMed ID: 32044716)
1. Silencing METTL3 inhibits the proliferation and invasion of osteosarcoma by regulating ATAD2. Zhou L; Yang C; Zhang N; Zhang X; Zhao T; Yu J Biomed Pharmacother; 2020 May; 125():109964. PubMed ID: 32044716 [TBL] [Abstract][Full Text] [Related]
2. The m6A methyltransferase METTL3 promotes osteosarcoma progression by regulating the m6A level of LEF1. Miao W; Chen J; Jia L; Ma J; Song D Biochem Biophys Res Commun; 2019 Aug; 516(3):719-725. PubMed ID: 31253399 [TBL] [Abstract][Full Text] [Related]
3. Dysregulated N6-methyladenosine methylation writer METTL3 contributes to the proliferation and migration of gastric cancer. Liu T; Yang S; Sui J; Xu SY; Cheng YP; Shen B; Zhang Y; Zhang XM; Yin LH; Pu YP; Liang GY J Cell Physiol; 2020 Jan; 235(1):548-562. PubMed ID: 31232471 [TBL] [Abstract][Full Text] [Related]
4. m6A-dependent up-regulation of DRG1 by METTL3 and ELAVL1 promotes growth, migration, and colony formation in osteosarcoma. Ling Z; Chen L; Zhao J Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32266933 [TBL] [Abstract][Full Text] [Related]
5. METTL3 promotes the progression of osteosarcoma through the N6-methyladenosine modification of MCAM via IGF2BP1. Song D; Wang Q; Yan Z; Su M; Zhang H; Shi L; Fan Y; Zhang Q; Yang H; Zhang D; Liu Q Biol Direct; 2024 Jun; 19(1):44. PubMed ID: 38849910 [TBL] [Abstract][Full Text] [Related]
6. METTL3 facilitates tumor progression via an m Li T; Hu PS; Zuo Z; Lin JF; Li X; Wu QN; Chen ZH; Zeng ZL; Wang F; Zheng J; Chen D; Li B; Kang TB; Xie D; Lin D; Ju HQ; Xu RH Mol Cancer; 2019 Jun; 18(1):112. PubMed ID: 31230592 [TBL] [Abstract][Full Text] [Related]
7. Analysis of the function and mechanism of DIRAS1 in osteosarcoma. Liu H; Shu W; Liu T; Li Q; Gong M Tissue Cell; 2022 Jun; 76():101794. PubMed ID: 35413492 [TBL] [Abstract][Full Text] [Related]
8. Silencing of ATPase family AAA domain-containing protein 2 inhibits migration and invasion of colorectal cancer cells. Hong S; Bi M; Yan Z; Sun D; Ling L; Zhao C Neoplasma; 2016; 63(6):846-855. PubMed ID: 27565322 [TBL] [Abstract][Full Text] [Related]
9. Overexpression of ATAD2 indicates Poor Prognosis in Oral Squamous Cell Carcinoma. Wang XL; Wang S; Wu ZZ; Yang QC; Li H; Xiong HG; Wan SC; Sun ZJ Int J Med Sci; 2020; 17(11):1598-1609. PubMed ID: 32669963 [TBL] [Abstract][Full Text] [Related]
10. METTL3 promotes the proliferation and invasion of esophageal cancer cells partly through AKT signaling pathway. Hou H; Zhao H; Yu X; Cong P; Zhou Y; Jiang Y; Cheng Y Pathol Res Pract; 2020 Sep; 216(9):153087. PubMed ID: 32825955 [TBL] [Abstract][Full Text] [Related]
11. HIF1α-dependent upregulation of ATAD2 promotes proliferation and migration of stomach cancer cells in response to hypoxia. Nayak A; Roy AD; Rout N; Singh SP; Bhattacharyya A; Roychowdhury A Biochem Biophys Res Commun; 2020 Mar; 523(4):916-923. PubMed ID: 31959473 [TBL] [Abstract][Full Text] [Related]
12. NEAT1_2 functions as a competing endogenous RNA to regulate ATAD2 expression by sponging microRNA-106b-5p in papillary thyroid cancer. Sun W; Lan X; Zhang H; Wang Z; Dong W; He L; Zhang T; Zhang P; Liu J; Qin Y Cell Death Dis; 2018 Mar; 9(3):380. PubMed ID: 29515109 [TBL] [Abstract][Full Text] [Related]
13. Aspirin Exerts Its Antitumor Effect in Esophageal Squamous Cell Carcinoma by Downregulating the Expression of ATAD2 and KIF4A. Zhang M; Ren Z; Wang X; Liu C; Zheng Z; Zhao J; Liu H Anal Cell Pathol (Amst); 2022; 2022():7005328. PubMed ID: 36046597 [TBL] [Abstract][Full Text] [Related]
14. METTL3-mediated m6A modification of CDCA7 mRNA promotes COAD progression. Hua M; Zhai X; Chen Y; Yin D Pathol Res Pract; 2024 Aug; 260():155437. PubMed ID: 38959625 [TBL] [Abstract][Full Text] [Related]
15. METTL3 Promotes Tumorigenesis and Metastasis through BMI1 m Liu L; Wu Y; Li Q; Liang J; He Q; Zhao L; Chen J; Cheng M; Huang Z; Ren H; Chen J; Peng L; Gao F; Chen D; Wang A Mol Ther; 2020 Oct; 28(10):2177-2190. PubMed ID: 32621798 [TBL] [Abstract][Full Text] [Related]
16. YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer. Li J; Xie H; Ying Y; Chen H; Yan H; He L; Xu M; Xu X; Liang Z; Liu B; Wang X; Zheng X; Xie L Mol Cancer; 2020 Oct; 19(1):152. PubMed ID: 33121495 [TBL] [Abstract][Full Text] [Related]
17. RNA m Luo G; Xu W; Zhao Y; Jin S; Wang S; Liu Q; Chen X; Wang J; Dong F; Hu DN; Reinach PS; Yan D J Cell Physiol; 2020 Oct; 235(10):7107-7119. PubMed ID: 32017066 [TBL] [Abstract][Full Text] [Related]
18. Silencing of METTL3 effectively hinders invasion and metastasis of prostate cancer cells. Chen Y; Pan C; Wang X; Xu D; Ma Y; Hu J; Chen P; Xiang Z; Rao Q; Han X Theranostics; 2021; 11(16):7640-7657. PubMed ID: 34335955 [No Abstract] [Full Text] [Related]
19. Effect of chronic intermittent hypoxia-induced HIF-1α/ATAD2 expression on lung cancer stemness. Hao S; Li F; Jiang P; Gao J Cell Mol Biol Lett; 2022 Jun; 27(1):44. PubMed ID: 35672694 [TBL] [Abstract][Full Text] [Related]
20. PSMC2 is up-regulated in osteosarcoma and regulates osteosarcoma cell proliferation, apoptosis and migration. Song M; Wang Y; Zhang Z; Wang S Oncotarget; 2017 Jan; 8(1):933-953. PubMed ID: 27888613 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]